The Richmond Club

Company: MEI Pharma Inc.
Symbol: MEIP:US
Length: 00:25:55
Presenter: Dr. Dan Gold, President & CEO
Occasion: Richmond Club Lunch, Toronto
MEI Pharma is a San Diego-based oncology company focused on the clinical development of novel therapies for cancer.

Additional Information
MEI Pharma is a San Diego-based oncology company focused on the clinical development of novel therapies for cancer. Our portfolio of drug candidates includes Pracinostat, an oral HDAC inhibitor that is being developed in combination with azacitidine for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). Our clinical development pipeline also includes ME-401, a highly selective, oral PI3K delta inhibitor, voruciclib, an oral, selective CDK inhibitor, and ME-344, a novel mitochondrial inhibitor.
Head Office:

MEI Pharma, Inc.
3611 Valley Centre Drive, Suite 500
San Diego, CA 92130

(858) 369-7100

W: www.meipharma.com

Get Access to The Richmond Clubs Latest Stock Picks

 

Don’t miss your chance to get in on the top stocks we think are the best buys now inside our exclusive Richmond Club Stock Advisor Letter.

Led by Chartered Investment Manager, Greg Beckett, the average stock pick inside The Richmond Club is up 1,301% vs. just 153% for the S&P.

This is your opportunity to become part of an exclusive membership led by the Richmond Club that has seen an average of 16.45 % gains over the past 15 years!

If you want to take advantage of this buying opportunity, simply enter your email address below to access our secure sign-up page.

By submitting your email address, you consent to us keeping you informed about updates to our website and about other products and services that we think might interest you. You can unsubscribe at any time. Please read our Privacy Policy